41493611000001109: Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual medicinal product\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual therapeutic moiety\Lercanidipine\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual therapeutic moiety\Lercanidipine\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing calcium channel blocker\Product containing lercanidipine\Lercanidipine\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing calcium channel blocker\Product containing lercanidipine\Lercanidipine\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing calcium channel blocker\Product containing lercanidipine\Product containing lercanidipine in oral dose form (medicinal product form)\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lercanidipine\Lercanidipine\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lercanidipine\Lercanidipine\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lercanidipine\Product containing lercanidipine in oral dose form (medicinal product form)\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing lercanidipine in oral dose form (medicinal product form)\Product containing only lercanidipine in oral dose form (medicinal product form)\Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet\Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2881851000001118 Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2881861000001115 Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Is a	Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has specific active ingredient	Lercanidipine hydrochloride	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd) 28 tablet	Has AMP	True	Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2881851000001118	Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2881861000001115	Lercanidipine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module